Lonza has announced the addition of two new Ibex Solutions offerings to Lonza’s 100,000 m2 biopark in Visp (CH).    In July 2017 IbexTM Dedicate, a modular, technology-agnostic biomanufacturing concept, was launched as the first IbexTM Solutions offering. IbexTM Dedicate offers an innovative facility concept with reduced CAPEX and accelerated timelines, enabling speed to market or allowing biopharma companies to delay investment decisions to decrease financial risk.       T...